DURECT Corp (DRRX), Pain Therapeutics (PTIE) Remoxy ER doesn't qualify for FD&C Act exemption - FDA

September 14, 2016 10:25 AM EDT
Get Alerts PTIE Hot Sheet
Trade PTIE Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

FDA says DURECT Corp (NASDAQ: DRRX) and Pain Therapeutics (NASDAQ: PTIE) Remoxy ER doesn't qualify for FD&C Act exemption.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Trader Talk

Add Your Comment